عنوان رویداد:
بیست و دومین کنفرانس شیمی معدنی ایران
برگزار شده توسط:دانشگاه کردستان
تاریخ برگزاری : 01 شهريور 1402
عنوان مقاله:
Virtual screening of human glyoxalase I inhibitors: A structure-based approach
نویسندگان:
خالد حسینی، مهدی ایرانی
دانلود فایلHuman glyoxalase I (GlxI) is a key metalloenzyme involved in the detoxification of methylglyoxal, a cytotoxic byproduct of glycolysis. GlxI is overexpressed in many cancers and contributes to their proliferation, invasion, and drug resistance. Therefore, this enzyme is a potential target for anticancer drug discovery. In this study, we performed a virtual screening of a large library of compounds to identify novel inhibitors of GlxI. We performed molecular docking using IGEMDOCKv2.1 software to find ligands that bind to the active site of GlxI. We used S-P-bromobenzylglutathione, a known inhibitor of GlxI with a very low KI value of 83 nM [1], as a probe ligand. Docking was performed on the human GlxI structure from the Protein Data Bank entry 1qip [2] (Figure 1 shows the binding pose of the probe ligand in the active site of the enzyme). Then we used web servers to generate and search pharmacophore models based on the probe ligand). We selected the top candidates and docked them to GlxI using AutoDock Vina. We ranked the compounds by their binding energies and selected the best ones for further analysis. We evaluated the binding modes and interactions of the selected inhibitors with GlxI and compared them with the known inhibitors. We also performed ADMET prediction and drug-likeness analysis to assess the pharmacological properties of the selected inhibitors. Our results suggest that we have identified some promising candidates that can inhibit GlxI with high affinity and specificity. These compounds may serve as lead compounds for further optimization and development of novel anticancer agents. Figure 1. The binding pose of the probe ligand (pink) in the active site of the enzyme). Keywords: Glyoxalase I, drug design, docking, virtual screening References [1] B. Mannervik, Biochemical Journal 1996, 314 (2), 463. [2] A. D. Cameron, M. Ridderström, B. Olin, M. J Kavarana, D. J Creighton, B. Mannervik, Biochemistry 1999, 38 (41), 13480.
Keywords: Glyoxalase I, drug design, docking, virtual screening
برای لینکدهی به این مقاله از آدرس زیر استفاده نمایید:
برای ارجاع در منابع از عبارت زیر استفاده کنید:
حسینی، خالد، ایرانی، مهدی، 1402، Virtual screening of human glyoxalase I inhibitors: A structure-based approach، بیست و دومین کنفرانس شیمی معدنی ایران، https://conference.uok.ac.ir/fa/archive_index.php?c=HN-iicc22&aid=1517784
دیگر مقالات این رویداد:
- One-step synthesis of titanate microstructures as efficient light scattering layer for dye-sensitized solar cells
shadi negahdari
- Ce/SiQDs as pseudo-enzymatic catalase to inhibit H2O2 inside the cells of the body
افسانه ملازاده، مهدیه قبادی فر، سجاد محبی
- Synthesis of Fe-MOF nanostructure: A Study of Peroxidase-Like behavior for Sensing of H2O2
آزیتا محمدی
- Investigation of catalytic activity of oxovanadium(IV) unsymmetrical salen complex in the oxidative coupling of thiols to disulfides with UHP
مهدی براتی، مهدی هاتفی اردکانی
- Introduction of a new DABCO-based ionic liquid as an efficient catalyst for the synthesis of benzimidazoquinazolinone derivatives
فاطمه میرزایی اسلاملو
- Tris(2-aminoethyl)amine-based metal complexes as new pH-sensitive drug vehicles
فرشید حاجی بابایی، سمانه صانعی موفق، صادق صالح زاده
تماس با ما
ایران، سنندج، بلوار پاسداران، دانشگاه کردستان، معاونت پژوهش و نوآوری
کدپستی: 15175-66177
تلفن: 33624008-087
پست الکترونیک: conference@uok.ac.ir
© کلیه حقوق متعلق به دانشگاه کردستان میباشد. (همایش نگار نسخه 11.0.1 )